Experimental study evaluates symptom validity measure for youth, suggesting adjustments may be needed for accuracy.
These initial findings support the potential utility of the SRSI as a symptom validity measure for adolescents. The lower specificity at the standard cutoff than that found in experimental feigning studies in adults (.90 vs. ≥ .95) suggests that the cutoff may need to be raised in youth samples. Further validation in clinical populations is necessary before recommending its use in applied settings.
No takes yet. Share an insight, caveat, or question.
Dandachi-FitzGerald et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: